Maker of popular weedkiller amplifies fight against cancer
JEFFERSON CITY, Mo. (AP) — After failing in several U.S. states this year, global chemical manufacturer Bayer said Tuesday that it plans to amplify efforts to create a legal shield against a proliferation of lawsuits alleging it failed to warn that its popular weedkiller could cause cancer.
Bayer, which disputes the cancer claims, has been hit with about 170,000 lawsuits involving its Roundup weedkiller and has set aside $16 billion to settle cases. But the company contends the legal fight “is not sustainable” and is looking to state lawmakers for relief.
Bayer lobbied for legislation that could have blocked a central legal argument this year in Missouri, Iowa and Idaho — home, respectively, to its North America crop science division, a Roundup manufacturing facility and the mines from which its key ingredient is derived. Though bills passed at least one chamber in Iowa and Missouri, they ultimately failed in all three states.
Related articles
Vatican makes fresh overture to China, reaffirms that Catholic Church is no threat to sovereignty
ROME (AP) — The Vatican made another big overture to China on Tuesday, reaffirming the Catholic Chur2024-05-22Hungarian parliament approves Finland's accession to NATO
Members of the Hungarian parliament vote on Finland's accession to NATO in Budapest, Hungary, on Mar2024-05-22G20 Summit to be held in Bali, Indonesia
This photo taken on Nov. 13, 2022 shows an interior view of the media center for the upcoming 17th G2024-05-22WWF calls for global treaty to protect high seas
Photo taken on May 28, 2020 shows fishes and sea anemone at a marine ranch in the sea area of Wuzhiz2024-05-22Congo names third American in a foiled coup plot as mourners gather in Utah to remember plot leader
Congo’s army spokesman on Tuesday released the name of the third American involved a foiled coup plo2024-05-22US interference abroad: A brief timeline
The US has long attempted to mold other countries with its own values and political system in the na2024-05-22
atest comment